Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus cotrimoxazole for ocular toxoplasmosis
IRCT201401299820N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences, Farabi Eye Hospital, Farabi Eye Reaserch Center
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of azithromycin and trimethoprim + sulfamethoxazole in ocular toxoplasmosis (2 arms), sponsored by Tehran University of Medical Sciences, Farabi Eye Hospital, Farabi Eye Reaserch Center. Started Oct 2013; status: completed.
02
Drugs
azithromycintrimethoprim + sulfamethoxazole
03
Conditions
ocular toxoplasmosis
Beyond the preview
Go deeper on IRCT201401299820N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201401299820N5.